Testing effectiveness (Phase 2)Ended earlyNCT00208975
What this trial is testing
Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab
Who this might be right for
Lymphoma
Emory University 15